3
Clinical Trials associated with Zoster vaccine, Live(Changchun BCHT Biotechnology)多中心、随机、双盲、安慰剂对照评价40岁及以上人群接种带状疱疹减毒活疫苗保护效力的Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the protective efficacy of attenuated live herpes zoster vaccine in people aged 40 years and above
主要目的:评价接种带状疱疹减毒活疫苗30天后预防带状疱疹的保护效力。次要目的:评价接种带状疱疹减毒活疫苗后预防带状疱疹的保护效力及30天后预防实验室诊断带状疱疹的保护效力和接种后的安全性、免疫原性和免疫持久性。探索性目的:探索接种带状疱疹减毒活疫苗30天后预防/减轻带状疱疹后遗神经痛(PHN)的保护效力。
[Translation] Primary objective: To evaluate the protective efficacy of attenuated live zoster vaccine against herpes zoster 30 days after vaccination. Secondary objective: To evaluate the protective efficacy of attenuated live zoster vaccine against herpes zoster and the protective efficacy against laboratory-diagnosed herpes zoster 30 days after vaccination, as well as the safety, immunogenicity and immune persistence after vaccination. Exploratory objective: To explore the protective efficacy of attenuated live zoster vaccine against postherpetic neuralgia (PHN) 30 days after vaccination.
不同病毒含量带状疱疹减毒活疫苗在50岁及以上成人中的安全性研究
[Translation] Safety study of live attenuated herpes zoster vaccines with different virus contents in adults aged 50 years and above
评价不同病毒含量带状疱疹减毒活疫苗的免疫原性和安全性
[Translation] Evaluation of immunogenicity and safety of live attenuated herpes zoster vaccines with different virus contents
不同病毒含量带状疱疹减毒活疫苗在50岁及以上成人中的安全性研究
[Translation] Safety study of live attenuated herpes zoster vaccines with different virus contents in adults aged 50 years and above
通过对50岁及以上成人接种试验疫苗,探索疫苗的安全性
[Translation] Studying the safety of the vaccine by vaccinating adults aged 50 years and older
100 Clinical Results associated with Zoster vaccine, Live(Changchun BCHT Biotechnology)
100 Translational Medicine associated with Zoster vaccine, Live(Changchun BCHT Biotechnology)
100 Patents (Medical) associated with Zoster vaccine, Live(Changchun BCHT Biotechnology)
100 Deals associated with Zoster vaccine, Live(Changchun BCHT Biotechnology)